AI Verdict
LGNZZ has stronger fundamentals based on our AI analysis.
LGNZZ vs LFVN Fundamental Comparison
| Metric | LGNZZ | LFVN |
|---|---|---|
| Revenue | $268.1M | $96.5M |
| Net Income | $124.5M | $2.4M |
| Net Margin | 46.4% | 2.5% |
| ROE | 12.2% | 7.4% |
| ROA | 8.0% | 4.0% |
| Current Ratio | 22.23x | 2.03x |
| Debt/Equity | 0.03x | 0.00x |
| EPS | $6.13 | $0.19 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LGNZZ vs LFVN: Frequently Asked Questions
Is LGNZZ or LFVN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LGNZZ has stronger fundamentals. LGNZZ is rated BUY (75% confidence) while LFVN is rated SELL (68% confidence). This is not investment advice.
How does LGNZZ compare to LFVN fundamentally?
LIGAND PHARMACEUTICALS INC has ROE of 12.2% vs Lifevantage Corp's 7.4%. Net margins are 46.4% vs 2.5% respectively.
Which stock pays higher dividends, LGNZZ or LFVN?
LGNZZ has a dividend yield of N/A or no dividend while LFVN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LGNZZ or LFVN for long term?
For long-term investing, consider that LGNZZ has BUY rating with 75% confidence, while LFVN has SELL rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LGNZZ vs LFVN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LGNZZ vs LFVN, the AI consensus favors LGNZZ based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.